Nifty
Sensex
:
:
10654.55
35397.05
37.85 (0.36%)
136.51 (0.39%)

Pharmaceuticals & Drugs

Rating :
N/A

BSE: 531541 | NSE: Not Listed

5.95
-0.29 (-4.65%)
15-Nov-2018 | 4:01PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  5.96
  •  5.96
  •  5.95
  •  6.24
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  5050
  •  0.30
  •  20.37
  •  4.64

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 14.18
  • N/A
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 236.01
  • N/A
  • -0.28

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 44.95%
  • 3.76%
  • 49.97%
  • FII
  • DII
  • Others
  • 0.66%
  • 0.00%
  • 0.66%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -100.00
  • -100.00
  • -100.00

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -15.02
  • -

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -5.99
  • 13.27

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.69
  • 0.60
  • -0.83

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 15.44
  • 21.64
  • 21.10

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Jun 18
Jun 17
Var%
Mar 18
Mar 17
Var%
Dec 17
Dec 16
Var%
Sep 17
Sep 16
Var%
Net Sales
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBITDA
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBIDTM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PBT
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PATM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
-
103.19
403.66
287.26
162.12
Net Sales Growth
-
-74.44%
40.52%
77.19%
 
Cost Of Goods Sold
-
92.36
330.46
206.10
100.46
Gross Profit
-
10.83
73.20
81.16
61.67
GP Margin
-
10.50%
18.13%
28.25%
38.04%
Total Expenditure
-
104.11
360.78
240.04
132.93
Power & Fuel Cost
-
2.78
8.38
11.80
12.41
% Of Sales
-
2.69%
2.08%
4.11%
7.65%
Employee Cost
-
9.03
12.25
12.95
10.20
% Of Sales
-
8.75%
3.03%
4.51%
6.29%
Manufacturing Exp.
-
0.74
6.84
4.99
6.39
% Of Sales
-
0.72%
1.69%
1.74%
3.94%
General & Admin Exp.
-
0.81
2.36
3.40
2.66
% Of Sales
-
0.78%
0.58%
1.18%
1.64%
Selling & Distn. Exp.
-
0.06
0.49
0.80
0.82
% Of Sales
-
0.06%
0.12%
0.28%
0.51%
Miscellaneous Exp.
-
-1.66
0.00
0.00
0.00
% Of Sales
-
-1.61%
0%
0%
0%
EBITDA
-
-0.92
42.88
47.22
29.19
EBITDA Margin
-
-0.89%
10.62%
16.44%
18.01%
Other Income
-
0.25
0.37
1.89
0.25
Interest
-
23.98
18.41
20.58
13.48
Depreciation
-
9.62
9.97
10.86
6.12
PBT
-
-34.27
14.87
17.67
9.84
Tax
-
0.54
1.21
2.00
0.00
Tax Rate
-
-1.58%
8.14%
11.32%
0.00%
PAT
-
-34.82
14.00
15.11
9.84
PAT before Minority Interest
-
-34.82
13.67
15.67
9.84
Minority Interest
-
0.00
0.33
-0.56
0.00
PAT Margin
-
-33.74%
3.47%
5.26%
6.07%
PAT Growth
-
-
-7.35%
53.56%
 
Unadjusted EPS
-
-15.47
6.22
6.72
4.38

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
53.08
87.89
73.90
61.40
Share Capital
22.50
22.50
22.50
22.50
Total Reserves
30.58
65.39
51.40
38.90
Non-Current Liabilities
78.98
67.30
85.34
90.16
Secured Loans
32.79
20.00
36.89
53.78
Unsecured Loans
11.49
13.14
14.81
15.49
Long Term Provisions
0.00
0.00
0.00
0.00
Current Liabilities
263.52
256.48
184.62
98.43
Trade Payables
118.44
104.37
114.58
31.67
Other Current Liabilities
14.50
25.53
18.93
14.24
Short Term Borrowings
127.10
123.33
47.36
47.85
Short Term Provisions
3.50
3.25
3.75
4.67
Total Liabilities
395.58
411.67
345.62
249.99
Net Block
103.52
107.77
100.17
110.09
Gross Block
192.41
187.09
169.69
168.77
Accumulated Depreciation
88.89
79.33
69.53
58.68
Non Current Assets
105.77
110.69
113.66
110.09
Capital Work in Progress
2.25
2.92
13.49
0.00
Non Current Investment
0.00
0.00
0.00
0.00
Long Term Loans & Adv.
0.00
0.00
0.00
0.00
Other Non Current Assets
0.00
0.00
0.00
0.00
Current Assets
289.81
300.99
231.95
139.90
Current Investments
0.00
0.00
0.00
0.00
Inventories
76.01
59.31
44.35
49.33
Sundry Debtors
189.62
204.73
147.05
63.39
Cash & Bank
5.64
16.48
25.13
2.49
Other Current Assets
18.53
0.43
0.52
0.35
Short Term Loans & Adv.
4.76
20.04
14.90
24.34
Net Current Assets
26.28
44.51
47.33
41.47
Total Assets
395.58
411.68
345.61
249.99

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
6.72
36.72
63.89
0.00
PBT
-34.27
14.87
17.67
0.00
Adjustment
33.60
28.37
31.44
0.00
Changes in Working Capital
7.94
-4.74
16.78
0.00
Cash after chg. in Working capital
7.26
38.51
65.89
0.00
Interest Paid
0.00
0.00
0.00
0.00
Tax Paid
-0.54
-1.79
-2.00
0.00
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
Cash From Investing Activity
-4.71
-6.99
-14.43
0.00
Net Fixed Assets
-4.65
-6.83
-14.41
Net Investments
0.00
-1.43
-10.76
Others
-0.06
1.27
10.74
Cash from Financing Activity
-12.85
-38.39
-26.82
0.00
Net Cash Inflow / Outflow
-10.84
-8.66
22.64
0.00
Opening Cash & Equivalents
16.48
25.13
2.49
0.00
Closing Cash & Equivalent
5.64
16.48
25.13
0.00

Financial Ratios

Standalone /

Consolidated
Description
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
23.59
39.06
32.84
27.29
ROA
-8.63%
3.61%
5.26%
3.94%
ROE
-49.39%
16.89%
23.17%
16.03%
ROCE
-4.10%
14.41%
19.89%
12.10%
Fixed Asset Turnover
0.55
2.32
1.74
1.01
Receivable days
692.18
155.15
130.31
135.12
Inventory Days
237.52
45.72
58.01
105.14
Payable days
364.22
105.87
111.17
80.09
Cash Conversion Cycle
565.47
95.00
77.15
160.17
Total Debt/Equity
3.38
2.07
1.60
2.14
Interest Cover
-0.43
1.81
1.86
1.73

News Update:


  • Avon Lifescien - Quarterly Results
    14th Aug 2018, 16:06 PM

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.